Glaukos Expired
Glaukos is a medical technology company specializing in innovative treatments for glaucoma, corneal disorders, and retinal diseases. The company is best known for pioneering minimally invasive glaucoma surgery (MIGS) with the iStent family of devices, which are implanted during cataract surgery to reduce intraocular pressure in patients with open-angle glaucoma. Glaukos has expanded its portfolio to include the iStent inject W and iStent infinite, as well as the iDose TR, a sustained-release intraocular drug delivery implant. The company is also advancing therapies in corneal cross-linking and retinal disease through its pipeline of biologics and sustained drug delivery platforms. Glaukos is focused on transforming the standard of care in chronic eye disease with safe, effective, and minimally invasive solutions.